We are live on ! Find out more
TA

Teachers Advisors Portfolio holdings

AUM $81.7B
1-Year Est. Return 13.62%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+13.62%
3 Year Est. Return
+67.19%
5 Year Est. Return
+103.94%
10 Year Est. Return
AUM
$74B
AUM Growth
+$2.63B
Cap. Flow
-$571M
Cap. Flow %
-0.77%
Top 10 Hldgs %
12.3%
Holding
3,163
New
40
Increased
1,261
Reduced
1,247
Closed
61

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$147M
2
PFE icon
Pfizer
PFE
+$109M
3
MSFT icon
Microsoft
MSFT
+$101M
4
MA icon
Mastercard
MA
+$94.4M
5
ABBV icon
AbbVie
ABBV
+$91.9M

Sector Composition

Rank Sector Weight
1 Financials 16.04%
2 Technology 15.59%
3 Healthcare 13.04%
4 Industrials 10.41%
5 Consumer Discretionary 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICPT
2176
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.1M ﹤0.01%
18,976
+546
+3% +$58.8K
OXFD
2177
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.1M ﹤0.01%
65,358
+9,684
+17% +$158K
ANAT
2178
DELISTED
American National Group, Inc. Common Stock
ANAT
$1.09M ﹤0.01%
9,267
-418
-4% -$49.2K
IXYS
2179
DELISTED
IXYS Corp
IXYS
$1.09M ﹤0.01%
46,163
+1,478
+3% +$28.1K
VRTV
2180
DELISTED
VERITIV CORPORATION
VRTV
$1.09M ﹤0.01%
33,629
-53
-0.2% -$1.77K
SSTK icon
2181
Shutterstock
SSTK
$222M
$1.09M ﹤0.01%
32,786
-579
-2% -$21.4K
TELL
2182
DELISTED
Tellurian Inc.
TELL
$1.09M ﹤0.01%
101,909
-1,036
-1% -$9.94K
EVC icon
2183
Entravision Communication
EVC
$1.01B
$1.08M ﹤0.01%
190,254
+7,695
+4% +$46.4K
PRTK
2184
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.08M ﹤0.01%
43,191
+418
+1% +$9.73K
GNMK
2185
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.08M ﹤0.01%
112,532
+3,757
+3% +$39K
KEYW
2186
DELISTED
The KEYW Holding Corporation
KEYW
$1.08M ﹤0.01%
142,357
+12,929
+10% +$105K
TRUP icon
2187
Trupanion
TRUP
$1.12B
$1.08M ﹤0.01%
40,935
-14,838
-27% -$341K
GOOD
2188
Gladstone Commercial Corp
GOOD
$629M
$1.08M ﹤0.01%
48,485
VIVO
2189
DELISTED
Meridian Bioscience Inc
VIVO
$1.08M ﹤0.01%
75,403
+3,574
+5% +$51.1K
CYTK icon
2190
Cytokinetics
CYTK
$10.9B
$1.08M ﹤0.01%
74,275
DCOM icon
2191
Dime Commercial Bancshares
DCOM
$1.81B
$1.08M ﹤0.01%
31,723
-1,444
-4% -$46.3K
RYAM icon
2192
Rayonier Advanced Materials
RYAM
$583M
$1.07M ﹤0.01%
78,405
LJPC
2193
DELISTED
La Jolla Pharmaceutical Company
LJPC
$1.07M ﹤0.01%
30,859
AXDX
2194
DELISTED
Accelerate Diagnostics
AXDX
$1.07M ﹤0.01%
4,757
+37
+0.8% +$9.09K
WHG icon
2195
Westwood Holdings Group
WHG
$187M
$1.07M ﹤0.01%
15,873
KERX
2196
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.07M ﹤0.01%
150,327
+4,099
+3% +$29.5K
JBSS icon
2197
John B. Sanfilippo & Son
JBSS
$997M
$1.06M ﹤0.01%
15,824
-230
-1% -$14.7K
FMI
2198
DELISTED
Foundation Medicine, Inc.
FMI
$1.06M ﹤0.01%
26,464
+736
+3% +$28.4K
SNEX icon
2199
StoneX
SNEX
$8.96B
$1.06M ﹤0.01%
140,110
+274
+0.2% +$2K
BCRX icon
2200
BioCryst Pharmaceuticals
BCRX
$2.44B
$1.06M ﹤0.01%
201,879
+5,494
+3% +$28.1K

Similar funds

Teachers Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Teachers Advisors held 3,163 positions worth $74B, up 3.7% from $71.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 3.2%. Teachers Advisors opened 40 new positions and exited 61, leaving the 3,163-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Teachers Advisors's largest Q3 2017 buy was Knight Transportation: 2,197,287 shares worth $91.3M.
  • Teachers Advisors added most to DuPont de Nemours in Q3 2017, an estimated $147M increase.
  • Teachers Advisors's biggest Q3 2017 reduction was Comcast, cutting an estimated $94M.
  • Teachers Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $133M.
  • Teachers Advisors's ten largest holdings make up 12% of its $74B portfolio in Q3 2017.
  • Teachers Advisors opened 40 new positions and closed 61 in Q3 2017.
  • Teachers Advisors's portfolio value rose 3.7% quarter-over-quarter to $74B.

Based on Teachers Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.